HomeAKTS • NASDAQ
add
Aktis Oncology Inc
Previous close
$17.89
Day range
$16.81 - $18.63
Year range
$14.72 - $29.16
Market cap
911.59M USD
Avg Volume
435.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.87M | 100.43% |
Operating expense | 70.20M | 1,671.91% |
Net income | -15.14M | -25.56% |
Net profit margin | -809.52 | 37.35% |
Earnings per share | — | — |
EBITDA | -16.68M | -9.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 226.79M | -23.68% |
Total assets | 264.88M | -18.79% |
Total liabilities | 77.62M | -3.66% |
Total equity | 187.26M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.14M | -25.56% |
Cash from operations | -15.24M | -19.08% |
Cash from investing | -126.46M | 26.85% |
Cash from financing | -772.00K | 57.21% |
Net change in cash | -142.47M | 24.01% |
Free cash flow | — | — |
About
Founded
2020
Website
Employees
76
